Reishi

Ganoderma Tsugae Reishi, also known as the Hemlock Varnish Shelf, is a species of mushroom known for its potential medicinal properties. A close relative Ganoderma Lucidum, used for thousands of years in Chinese medicine, Ganoderma tsugae grows wild and prolifically in the hemlock forests of Maine. Let's explore the medicinal benefits of Ganoderma tsugae, supported by scientific research.

​

Immune System Support:

 

Ganoderma tsugae is believed to possess immunomodulatory effects, supporting and modulating the immune system. A study published in the Journal of Ethnopharmacology investigated the immunomodulatory properties of Ganoderma tsugae extract. The results demonstrated that the extract enhanced the activity of immune cells, such as natural killer cells and T cells. These findings suggest that Ganoderma tsugae may help strengthen the immune system and support overall immune function.

 

Antioxidant and Anti-inflammatory Effects:

 

Ganoderma tsugae contains bioactive compounds that exhibit potent antioxidant and anti-inflammatory properties. These properties contribute to its potential health benefits. A study published in the Journal of Agricultural and Food Chemistry evaluated the antioxidant activity of Ganoderma tsugae extract. The results showed that the extract exhibited significant antioxidant effects, helping to scavenge free radicals and reduce oxidative stress.

Furthermore, studies have indicated that Ganoderma tsugae may possess anti-inflammatory effects. A study published in the Journal of Ethnopharmacology investigated the anti-inflammatory activity of Ganoderma tsugae extract in animal models. The results demonstrated its ability to reduce inflammation by inhibiting the production of pro-inflammatory cytokines. These findings suggest that Ganoderma tsugae may have potential applications in managing inflammatory conditions.

​

Potential Anticancer Activity:

 

Research has explored the potential anticancer properties of Ganoderma tsugae, focusing on its bioactive compounds and their effects on cancer cells. A study published in the journal PLOS ONE investigated the anticancer effects of Ganoderma tsugae extract on human colon cancer cells. The results showed that the extract inhibited cancer cell growth and induced apoptosis (cell death) in the cancer cells. Another study published in the Journal of Ethnopharmacology evaluated the anticancer potential of Ganoderma tsugae extract on liver cancer cells. The extract was found to suppress cancer cell proliferation and induce cell cycle arrest. These studies suggest that Ganoderma tsugae may possess potential anticancer activity, although further research is needed to fully understand its mechanisms and potential clinical applications.

 

Cardiovascular Health:

 

Ganoderma tsugae has also been investigated for its potential cardiovascular health benefits. A study published in the Journal of Food and Drug Analysis examined the effects of Ganoderma tsugae extract on blood pressure and cholesterol levels in rats with hypertension. The results demonstrated that the extract significantly reduced blood pressure and improved lipid profiles, indicating potential cardiovascular protective effects. However, more research is needed to explore its cardiovascular benefits in humans.

 

 

​

It's important to note that while Ganoderma tsugae shows promise as a medicinal mushroom, more extensive research is needed to validate its effectiveness and fully understand its therapeutic mechanisms. As always, it is advisable to consult with a healthcare professional before incorporating Ganoderma tsugae or any other supplements into your routine, especially if you have underlying health conditions or are taking medications.

​

​

The following is an article from The Journal of Alternative and Complementary Medicine

​

​

Comparative Studies of Various Ganoderma Species and Their Different Parts with Regard to Their Antitumor and Immunomodulating Activities In Vitro

 

Grace G.L. Yue, Kwok-Pui Fung, Gary M.K. Tse, Ping-Chung Leung, and Clara B.S. Lau

Published Online: 11 Oct 2006 https://doi.org/10.1089/acm.2006.12.777

 

Abstract

Objectives:Ganoderma lucidum (Lingzhi or Reishi) has been commonly suggested in East Asia as a potential candidate for prevention and treatment of different diseases, including cancer. Ganoderma extracts, in particular Ganoderma lucidum (extracts or isolated components), have previously been shown to possess antitumor activities. The present study aimed at comparing three different species of Ganoderma, wildly grown versus cultivated, as well as the different parts of the fruiting body (whole fruiting body, pileus, and stipe), with regard to their antitumor effects in human breast cancer cells and immunomodulatory activities in mouse splenic lymphocytes in vitro.

​

Methods: The aqueous extracts (12.5-400 µg/mL) of G. lucidum, G. sinense, and G. tsugae were examined for their antiproliferative activities in human breast cancer cell lines, MCF-7 and MDA-MB-231, as well as in normal human mammary epithelial cells (primary culture). The immunomodulatory effects of the extracts were evaluated in mouse splenic lymphocytes. The proliferative responses of the mentioned cell types were determined by MTT [3-(4,5-dimethylthiazolyl)-2,5-diphenyl-tetrazolium bromide] assay.

 

Results: The present results demonstrated that the extracts of all tested Ganoderma samples could significantly inhibit cell proliferation in human breast cancer cell lines MCF-7 and MDA-MB-231, with G. tsugae being the most potent. The extracts, however, did not exert any significant cytotoxic effect on human normal mammary epithelial cells. Within the species G. sinense, the inhibitory effects of wildly grown samples were not significantly different from those of the cultivated samples, except at 400 µg/mL. Most of the tested extracts of Ganoderma stimulated mouse splenic lymphocytes proliferation. The extracts from the stipes of the G. tsugae and wildly grown G. sinense showed much stronger inhibitory effects than the other parts of the fruiting body in both cancer cell lines, whereas the extracts from the stipes of G. lucidum and wildly grown G. sinense showed stronger immunopotentiating activities in mouse splenic lymphocytes.

​

Conclusions: These results indicate that the aqueous extracts of these commonly available Ganoderma fruiting bodies, G. lucidum, G. sinense, and G. tsugae have antitumor activities in human breast cancer cells and immunomodulatory activities in murine lymphocytes. In addition, the present findings also suggest that the stipes of fruiting bodies of Ganoderma species should be included in the preparation of extract of these fungi in order to obtain the most comprehensive active ingredients. To the best of the authors' knowledge, this is the first detailed comparison among the different parts of the fruiting bodies of Ganoderma.